Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus
about
Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routesIn vivo assessment of natural killer cell responses during chronic feline immunodeficiency virus infectionAcute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.Partial regulatory T cell depletion prior to acute feline immunodeficiency virus infection does not alter disease pathogenesisIn vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virusPrior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge.Pathogenicity and immunogenicity of a vaccine strain of Listeria monocytogenes that relies on a suicide plasmid to supply an essential gene product.Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges.Advances in FIV vaccine technology.SHIV antigen immunization alters patterns of immune responses to SHIV/malaria coinfection and protects against life-threatening SHIV-related malaria.Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection.Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).HIV infection and specific mucosal immunity: workshop 4B.
P2860
Q22241377-B76726F7-BD03-466A-B7AF-EAA960F99FF4Q27302300-30CA1926-FBE1-46C3-A95A-C480280AFE04Q33715758-10621C1C-1786-44A0-9F22-A0397CF54A9AQ33833910-AA80C2E8-A624-4E65-A51C-A2DFE2520DF5Q33889113-D5C277C2-5141-4501-89AF-560E60734047Q33968779-F29EFA51-F1D1-4A83-A7EA-112D47B33B0FQ34033905-98E6F86A-4274-4FED-A3ED-BFB0F636CAD7Q35066276-8F1761B9-122E-40D2-9CC7-24302025DABFQ35160124-5A03975E-422A-4168-808D-401D5FA4D0BEQ36634847-56F405BB-B762-47D6-B99B-50254EF20126Q36936342-603AAACC-A879-441E-89C6-F112D08ACE1EQ37060583-B2D8EEE2-A2DB-4222-A629-8ACC0FF0CC51Q37967232-B767D6A9-FB20-48D5-827A-717DFA5D500AQ43994786-E3B75E7D-DC02-465D-9B0C-FA17C15D9D00
P2860
Oral immunization with recombinant listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Oral immunization with recombi ...... feline immunodeficiency virus
@ast
Oral immunization with recombi ...... feline immunodeficiency virus
@en
type
label
Oral immunization with recombi ...... feline immunodeficiency virus
@ast
Oral immunization with recombi ...... feline immunodeficiency virus
@en
prefLabel
Oral immunization with recombi ...... feline immunodeficiency virus
@ast
Oral immunization with recombi ...... feline immunodeficiency virus
@en
P2093
P2860
P1433
P1476
Oral immunization with recombi ...... feline immunodeficiency virus
@en
P2093
Kristina E Howard
MaryJo Burkhard
Rosemary Stevens
Sushila Nordone
P2860
P304
P356
10.1128/JVI.78.15.8210-8218.2004
P407
P50
P577
2004-08-01T00:00:00Z